Granulocyte colony-stimulating factor (G-CSF) has been used clinically as an auxiliary chemotherapeutic agent due to its functionality in reducing chemotherapy-induced infections in cases of nonlymphoid malignancies, curing neutropenia and mobilizing hematopoietic cells into peripheral blood through binding to cognate cell surface receptors. Here, CSF3 is linked to neutropenia.